Literature DB >> 15315760

Mouse development and cell proliferation in the absence of D-cyclins.

Katarzyna Kozar1, Maria A Ciemerych, Vivienne I Rebel, Hirokazu Shigematsu, Agnieszka Zagozdzon, Ewa Sicinska, Yan Geng, Qunyan Yu, Shoumo Bhattacharya, Roderick T Bronson, Koichi Akashi, Piotr Sicinski.   

Abstract

D-type cyclins (cyclins D1, D2, and D3) are regarded as essential links between cell environment and the core cell cycle machinery. We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins. We found that these cyclin D1(-/-)D2(-/-)D3(-/-) mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia. Our analyses revealed that the D-cyclins are critically required for the expansion of hematopoietic stem cells. In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry. We found that the proliferation of cyclin D1(-/-)D2(-/-)D3(-/-) cells is resistant to the inhibition by p16(INK4a), but it critically depends on CDK2. Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation. Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-independent fashion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315760     DOI: 10.1016/j.cell.2004.07.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  269 in total

1.  Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.

Authors:  Glen J Weiss; Manuel Hidalgo; Mitesh J Borad; Daniel Laheru; Raoul Tibes; Ramesh K Ramanathan; Lisa Blaydorn; Gayle Jameson; Antonio Jimeno; Jeffrey D Isaacs; Angela Scaburri; Maria Adele Pacciarini; Francesco Fiorentini; Marina Ciomei; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2011-12-09       Impact factor: 3.850

Review 2.  Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis.

Authors:  Pierre Beukelaers; Renaud Vandenbosch; Nicolas Caron; Laurent Nguyen; Gustave Moonen; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

Review 3.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

Review 4.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

5.  The impact of C-MYC gene expression on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Hassan Ashktorab; Liucun Gao; Yanjie Xu; Kai Wu; Junshan Zhai; Lei Zhang
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

Review 6.  Regulating mitosis and meiosis in the male germ line: critical functions for cyclins.

Authors:  Debra J Wolgemuth; Shelby S Roberts
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

7.  E2f1-3 are critical for myeloid development.

Authors:  Prashant Trikha; Nidhi Sharma; Rene Opavsky; Andres Reyes; Clarissa Pena; Michael C Ostrowski; Martine F Roussel; Gustavo Leone
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

8.  Driving the cell cycle with a minimal CDK control network.

Authors:  Damien Coudreuse; Paul Nurse
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

9.  Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Authors:  Patrick J Roberts; John E Bisi; Jay C Strum; Austin J Combest; David B Darr; Jerry E Usary; William C Zamboni; Kwok-Kin Wong; Charles M Perou; Norman E Sharpless
Journal:  J Natl Cancer Inst       Date:  2012-02-01       Impact factor: 13.506

Review 10.  In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Authors:  Jonathan D Moore
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.